As Big Pharma makes evermore declarations on its sustainability credentials, who are the industry’s most sustainable companies? With wildlife under severe threat from biopharmaceutical run-off, which companies are truly dedicated to change? Which are truly dedicated to equitable pay structures and promoting diversity, equity and inclusion? To answer these questions, the Toronto-based media and research…
Featured Content
One of the doyens of European biotech is stepping back from general management. Jean-Paul Clozel founded rare disease focused Actelion along with his wife Martine Clozel in 1997, a company that went on to become publicly traded and launch three blockbuster drugs. The Clozels then sold up to J&J for an astonishing USD 30 billion…
A roundup of some of the biggest stories coming out of German pharma, including Merck’s better-than-expected Q1 earnings; Stada’s possible return to the stock market; CDMO Vetter’s expanded capacity in the US and Germany; Bayer’s elimination of some 1,500 jobs, and BioNTech’s bid for MediLink’s solid tumour platform. Merck KGaA’s Q1 adjusted profit declines…
We can't afford to have companies withdraw from infectious disease research—it's crucial for global health security
In Conversation
Henry Yau – Managing Director, HKU Clinical Trials Centre
We recognize the value of the existing infrastructure and services provided by both the new GBACTI and the existing HKU-CTC. By working together, we can ensure that resources are utilized efficiently and that the overall ecosystem for clinical research in Hong Kong is strengthened
Lionel Collet – President, Haute Autorité de Santé (HAS), France
Maintaining independence is paramount because we must never be beholden, in any way, to either industry interests or governmental influence.
NIH's Carl Dieffenbach on the Long Road to a HIV Vaccine
My goal has been to try to develop strategies and approaches that – when implemented at scale – could really have an impact on HIV incidence
Yu Wang – Chairman, Chinese Foundation for Hepatitis Prevention & Control
The regulatory environment in China, guided by the NMPA, appears to be evolving positively, providing a conducive framework for pharmaceutical innovation and growth
Fadi Ghanayem – Managing Director, bioMérieux Saudi Arabia & CCAIM
In Saudi Arabia, there is a keen interest in being at the forefront of adopting pioneering technologies and conducting research to validate their efficacy.
Alberto Navia-Osorio Pascual – Country Manager, Viatris Portugal
Our broad, global portfolio includes products that help treat the top 10 leading causes of death globally, as determined by the WHO
Emily Kainne Dokubo – Deputy US Global AIDS Coordinator for Program Quality, President’s Emergency Plan for AIDS Relief (PEPFAR)
Millions of lives have been saved, millions of people are on treatment, and millions of babies have been born HIV-free. We have achieved a lot, but there is still work to do
Ayman Abdo – SVP, Fakeeh Care Group
We are working towards creating a private sector ecosystem that can cater to broader healthcare transformation
Sanchit Chaturvedi – Managing Director, Halewood Laboratories
Success in business requires more than just aggression—it requires strategy, understanding, and relentless dedication
In Case You Missed It
InFigures
Belgium, with a total of EUR 5.5 billion in R&D spending in 2021, is the country with the fourth largest research expenditure in the EU and the first per inhabitant. As a recent study from Deloitte sponsored by the Belgian pharmaceutical industry association, pharma.be, shows, Belgium is also a leader in clinical trials, maintaining its…
Latin America will be the world’s fastest growing region for pharmaceuticals up to 2027, with a stunning expected compound annual growth rate of 22 percent, according to recent reporting from IQVIA. The Indian subcontinent can also expect sizeable growth over the next three years, although the US, Europe, and East Asia will remain the largest…
After the Hong Kong Exchanges and Clearing Limited’s (HKEX) 2018 move to allow pre-revenue biotech companies to raise capital in Hong Kong under its Chapter 18A mechanism, biotech listings surged with pre-clinical companies chosing to list on HKEX as a means of accessing global capital, raising around HKD 118 billion in funding. After a record…
The world’s top 10 medical technology companies for 2022 according to Medical Product Outsourcing (MPO). Abbott leads the way, followed by Medtronic, J&J, and Siemens Healthineers. Recent PharmaBoardroom interviews with some of these companies’ leading executives include Hugo F. Villegas, SVP & President, Canada & Latin America at Medtronic, Eman Ali, Regional Vice President for…
